Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Breast cancer imaging agent approved in Canada

Oct. 8, 1997

Potential early warning sign for heart transplant rejection

Oct. 8, 1997

ChemTrak reacquires rights to H. pylori test

Oct. 3, 1997

Alliance and Schering AG sign agreement for Imagent US

Sep. 25, 1997

Draxis Health subsidiary initiates phase I testing of DVT diagnostic agent

Sep. 25, 1997

Canadian clearance for CEA-Scan

Sep. 19, 1997

Trinity Biotech's rotavirus test kit approved by FDA

Sep. 19, 1997

Advanced Magnetics' liver contrast agent launched in Japan

Sep. 16, 1997

Final preclinical results for MRSA test reported

Sep. 16, 1997

Genzyme's second-generation LDL and HDL tests launched in U.S.

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...